Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
JMJD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PPP2R2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTPCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM149A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF628 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DESI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC94 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAVCR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATPAF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PACS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on